Improved method for the isolation and preliminary characterization of human DAF (decay-accelerating factor).

Article Details

Citation

Sugita Y, Negoro T, Matsuda T, Sakamoto T, Tomita M

Improved method for the isolation and preliminary characterization of human DAF (decay-accelerating factor).

J Biochem. 1986 Jul;100(1):143-50.

PubMed ID
2428813 [ View in PubMed
]
Abstract

DAF (decay-accelerating factor) is one of the integral membrane proteins of erythrocytes, and is considered to play an important role in the regulation of complement activation. The purification of DAF has been impeded by the difficulty in removing glycophorin. We devised an effective method for removing glycophorin. Through the limited trypsinization of stromata prior to the extraction of DAF, glycophorin was readily digested so that the DAF could be purified free of glycophorin by DEAE-Sephacel and Bio-Gel A 0.5 m chromatographies. On SDS-PAGE, DAF from trypsinized stromata showed the same mobility as that from native stromata: its molecular weight was estimated to be about 70 kDa. Amino acid analysis of DAF showed high contents of serine and glutamic acid. The amino-terminal sequence of DAF prepared by the present method, determined for the 29 residues, did not show significant homology with that of glycophorin.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Complement decay-accelerating factorP08174Details